NADPH oxidase 2 complex (NOX2) (NOX2)

Neutrophil superoxide anion generation is a fundamental biological process of the innate immune system, primarily executed by the NADPH oxidase 2 (NOX2) complex (UniProt P04839). This multicomponent enzyme, also known as cytochrome b-245, is composed of membrane-bound subunits (gp91phox and p22phox) and cytosolic factors (p47phox, p67phox, p40phox, and Rac) that assemble upon cell activation (PubMed: 28273476). Its primary function is the "respiratory burst," where it transfers electrons from NADPH to molecular oxygen to produce superoxide anions, which are precursors to potent microbicidal agents (PubMed: 15549124). While essential for killing pathogens, dysregulated or excessive superoxide production is a major driver of oxidative stress and tissue damage in chronic inflammatory conditions, such as rheumatoid arthritis and atherosclerosis (PubMed: 24560511). Genetic deficiencies in the components of this complex lead to Chronic Granulomatous Disease (CGD), characterized by severe, recurrent infections (StatPearls: NBK531487). Pharmacological targeting of NOX2 aims to reduce pathological ROS production without completely compromising host defense, using inhibitors like GSK2795039 (PubChem: CID 118957446). Monitoring the efficacy of such drugs often involves assays like dihydrorhodamine 123 (DHR) reduction or nitroblue tetrazolium (NBT) tests, which measure the output of the superoxide generation process. These biomarkers are critical for both diagnosing genetic deficiencies and evaluating the pharmacodynamic effects of NOX inhibitors in clinical development.

Other names

Cytochrome b-245gp91phoxRespiratory burst oxidaseNicotinamide adenine dinucleotide phosphate oxidase 2NOX2 complexgp91phox/p22phox complex

Inhibition of the NADPH oxidase 2 complex, preventing the transfer of electrons from NADPH to molecular oxygen and the subsequent generation of superoxide anions.